Traditional Chinese medicine stocks rose and strengthened, and Dali pharmaceutical touched the daily limit

Healthcare, Financials, Automotive Mar 10, 2022 09:49 AM (GMT+8) · EqualOcean

Traditional Chinese medicine stocks rose and strengthened. As of press time, Dali pharmaceutical touched the daily limit, zoelli pharmaceutical rose by more than 12%, and Panlong pharmaceutical, sunflower pharmaceutical, Hansen pharmaceutical, huluwa and Jichuan pharmaceutical rose by more than 5%.

This text is a result of machine translation.

Related companies：

Briefing Jun 27, 2022 10:35 AM · Consumer Staples

Huayou cobalt industry: the company has entered the industry chain of global head power batteries such as Ningde times and LG Chemical

Briefing Jun 24, 2022 11:09 AM · Technology | Financials

Russian finance minister says West creates artificial obstacles for Russia to repay public debt

In-depth

Automotive

China's NEV Market Reports Best February Sales Ever with 180.5% YoY Surge

The article analyzes the EV market from the perspective of sales, EV battery and infrastructure

Mar 22, 2022 02:16 PM

Briefing Jun 24, 2022 10:39 AM · Technology | Healthcare | Industrials

The maximum payment limit of employee medical insurance in Shanghai in 2022 was raised to 590000 yuan

Briefing Jun 23, 2022 09:45 PM · Automotive

Weilai automobile fell sharply at the beginning of the session and is now down 0.2%.

Research

Automotive

China Automotive Industry Trends to Watch 2023

Jan 06, 2023 08:30 AM

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Technology, Automotive

2022 China New Energy Tech Industry Report

Nov 08, 2022 08:32 AM

Research

Automotive, Technology

Global Auto Chip Shortage: Challenges, Opportunities and Implications for OEMs

Aug 04, 2021 03:41 PM

Briefing Jun 23, 2022 05:09 PM · Technology | Healthcare | Real Estate

DFT: the subsidiary Ningfu new energy signed a joint venture agreement with Guangzhou Juwan

Briefing Jun 23, 2022 03:49 PM · Technology | Automotive

Yangdian Technology: Zhou Feng plans to reduce his shareholding by no more than 5.71%

Briefing Jun 22, 2022 04:09 PM · Technology | Consumer Staples | Financials

South Africa's inflation rate reached 6.5%, breaking the target for the first time in five years.

Briefing Jun 22, 2022 08:59 AM · Financials | Automotive

CITIC Securities: it is estimated that the sales of new energy vehicles in June will reach 543-553 thousand

Healthcare · Analysis

EqualOcean｜China's Top 20 ESG Performers Among Private Enterprises（Part III）

Private enterprises are actively embracing the transformative era

Sep 28, 2023 10:00 AM

Automotive

NIO Reports Q2 Revenue Down 14.8% YoY to USD 1.2 Billion

Nio lost USD 835 million in the second quarter, more than twice its year-ago loss.

Sep 01, 2023 08:34 AM

Briefing Jun 18, 2022 03:39 PM · Automotive

Ruihu mold: the aluminum alloy lightweight body mold of Jihu alpha s model with automatic driving technology provided by Huawei is manufactured by the company

Briefing Jun 17, 2022 07:14 AM · Automotive

Transformation and acceleration several auto companies stated that they would stop producing fuel vehicles

Briefing Jun 16, 2022 08:24 PM · Technology | Financials | Automotive

Beyond technology: it is planned to issue no more than 450million yuan of convertible bonds

Industrials

NIO's New Battery Plant in Hungary Started Operation

NIO is expected to supply battery swap stations to its entire European network from the new 10,000-square meter plant located in Great Budapest Area.

Sep 19, 2022 12:19 PM

Healthcare

CRO ClinChoice Raises USD 150 Mn in Series E Round

2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.

Jul 05, 2022 08:17 PM

Briefing Jun 13, 2022 10:14 AM · Technology | Consumer Staples | Communication

The private placement market is full of chaos, and the regulators' sword is intended to support the good and limit the bad

Briefing Jun 13, 2022 09:44 AM · Healthcare

Cro plate fell, and Wuxi apptec fell nearly 10%

Briefing Jun 13, 2022 09:33 AM · Technology | Healthcare

The trading limit of AVIC electronics and AVIC electromechanical resumed

Briefing Jun 13, 2022 08:28 AM · Consumer Staples | Automotive

Macquarie gave velai's H shares an initial rating of outperformance, with a target price of HK $215.